Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
|||||||
GSE186412 |
The Human Milk Oligosaccharide 3’Sialyllactose Promotes Inflammation Resolution and Reduces Atherosclerosis Development in Mice
|
9 | Adam Cribbs | Oct 20, 2024 | ||||
GSE275458 |
ATF4-Mediated Metabolic Stress Response as a Therapeutic Vulnerability in Chordoma [MUG-Chor RNA-seq]
|
40 | Adam Cribbs | Aug 31, 2024 | ||||
GSE275636 |
ATF4-Mediated Metabolic Stress Response as a Therapeutic Vulnerability in Chordoma [PDX RNA-seq]
|
10 | Adam Cribbs | Aug 31, 2024 | ||||
GSE275637 |
ATF4-Mediated Metabolic Stress Response as a Therapeutic Vulnerability in Chordoma
|
50 | Adam Cribbs | Aug 31, 2024 | ||||
GSE134120 |
Combination of epigenetic enzyme inhibitors, GSKJ4 and Belinostat, reveals efficacy in IDH1 mutant gliomas
|
16 | Adam Cribbs | Jul 14, 2024 | ||||
GSE263458 |
Anchor-Enhanced Bead Design for Reduced Oligonucleotide Synthesis Errors in Single-cell sequencing
|
7 | Adam Cribbs | Apr 09, 2024 | ||||
GSE157032 |
Halofuginone is a potent inhibitor of SARS-CoV-2 Infection and Replication [Exp1]
|
19 | Adam Cribbs | Aug 28, 2023 | ||||
GSE157034 |
Halofuginone is a potent inhibitor of SARS-CoV-2 Infection and Replication [Exp2]
|
24 | Adam Cribbs | Aug 28, 2023 | ||||
GSE157036 |
Halofuginone is a potent inhibitor of SARS-CoV-2 Infection and Replication
|
61 | Adam Cribbs | Aug 28, 2023 | ||||
GSE166411 |
Halofuginone is a potent inhibitor of SARS-CoV-2 Infection and Replication [Exp3]
|
18 | Adam Cribbs | Aug 28, 2023 | ||||
GSE218899 |
Counting and correcting errors within unique molecular identifiers to generate absolute numbers of sequencing molecules [RNA-seq]
|
27 | Adam Cribbs | Jun 01, 2023 | ||||
GSE218901 |
Counting and correcting errors within unique molecular identifiers to generate absolute numbers of sequencing molecules [scRNA-Seq]
|
6 | Adam Cribbs | Jun 01, 2023 | ||||
GSE218903 |
Counting and correcting errors within unique molecular identifiers to generate absolute numbers of sequencing molecules
|
33 | Adam Cribbs | Jun 01, 2023 | ||||
GSE166493 |
Modification of histones and their transcriptional response
|
48 | Adam Cribbs | Feb 01, 2023 | ||||
GSE213291 |
KDM6 histone demethylase inhibitor GSK-J4 induces metal and stress responses in multiple myeloma cells [GSK-J4]
|
18 | Adam Cribbs | Sep 16, 2022 | ||||
GSE213292 |
KDM6 histone demethylase inhibitor GSK-J4 induces metal and stress responses in multiple myeloma cells [ZNSO]
|
39 | Adam Cribbs | Sep 16, 2022 | ||||
GSE213294 |
KDM6 histone demethylase inhibitor GSK-J4 induces metal and stress responses in multiple myeloma cells
|
57 | Adam Cribbs | Sep 16, 2022 | ||||
GSE190085 |
Electrospun scaffold micro-architecture induces an activated transcriptional phenotype within tendon fibroblasts. Bulk RNA-seq data.
|
48 | Adam Cribbs | Dec 05, 2021 | ||||
GSE166535 |
Loss of mutual protection between osteoclasts and chondrocytes in damaged joints: effects on osteoclast-mediated cartilage degradation via matrix metalloproteinases
|
24 | Adam Cribbs | Dec 01, 2021 | ||||
GSE134038 |
Single cell sequencing identifies novel sub-populations of breast cancer cells selected under hypoxia
|
384 | Adam Cribbs | Sep 09, 2021 |